- Q1 2024 Aadi Bioscience Inc Earnings Call TranscriptMay 08, 2024$1.84 (-12.80%)Earnings
- Q4 2023 Aadi Bioscience Inc Earnings Call TranscriptMar 13, 2024$2.16 (+11.34%)Earnings
- Aadi Bioscience Inc Investor Conferece Call TranscriptDec 14, 2023
- Aadi Bioscience Inc at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Aadi Bioscience Inc Earnings Call TranscriptNov 08, 2023$4.65 (-3.53%)Earnings
- Aadi Bioscience Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Aadi Bioscience Inc Earnings Call TranscriptAug 09, 2023$5.44 (-6.85%)Earnings
- Aadi Bioscience Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Aadi Bioscience Inc at TD Cowen Oncology Innovation Summit (Virtual) TranscriptMay 30, 2023
- Q1 2023 Aadi Bioscience Inc Earnings Call TranscriptMay 10, 2023$7.08 (-16.61%)Earnings
- Q4 2022 Aadi Bioscience Inc Earnings Call TranscriptMar 28, 2023$6.85 (-5.52%)Earnings
- Q3 2022 Aadi Bioscience Inc Earnings Call TranscriptNov 09, 2022$13.41 (+2.84%)Earnings
- Aadi Bioscience Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Aadi Bioscience Inc Earnings Call TranscriptAug 10, 2022$13.88 (-1.49%)Earnings
- Q1 2022 Aadi Bioscience Inc Earnings Call TranscriptMay 12, 2022$12.65 (+9.33%)Earnings
- Aadi Bioscience Inc FYARRO Corporate Call TranscriptNov 23, 2021
- Aadi Bioscience Inc at H C Wainwright Precision Oncology Conference (Virtual) TranscriptOct 20, 2021
- Q3 2020 Aerpio Pharmaceuticals Inc Earnings Call TranscriptNov 10, 2020Earnings
- Q2 2020 Aerpio Pharmaceuticals Inc Earnings Call TranscriptAug 12, 2020Earnings
- Aerpio Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 24, 2020
- Aerpio Pharmaceuticals, Inc. - Special Call TranscriptJun 12, 2020
- Q4 2019 Aerpio Pharmaceuticals Inc Earnings Call TranscriptMar 16, 2020Earnings
- Aerpio Pharmaceuticals, Inc. to Discuss the Results from the TIME-2b Study Conference Call TranscriptMar 18, 2019
- Q4 2018 Aerpio Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2019Earnings
Aerpio Pharmaceuticals, Inc. - Special Call Transcript
Greetings, and welcome to the Aerpio Pharmaceuticals KOL call on a novel mechanism for the treatment of glaucoma. (Operator Instructions) As a reminder, this conference is being recorded.
I'd now like to turn the conference over to your host, Joseph Gardner, President and Founder of Aerpio Pharmaceuticals. Thank you. You may begin.
Thank you, and thanks, everybody, for participating in this conference call this morning. We're very pleased and excited to be able to present more about our glaucoma program, and we're particularly pleased to have Dr. Paul Kaufman, MD, from the University of Wisconsin, as a presenter; as well as Dr. Janey Wiggs, from Harvard Medical Center, as a presenter as well.
We will be covering the novel mechanism for treating glaucoma. Dr. Kaufman will cover the current landscape and talk about the unmet needs. Dr. Wiggs will talk about the role of the Tie2 receptor in maintaining intraocular pressure. And I will
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)